BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24042025)

  • 1. Estimating the proportion cured of cancer: some practical advice for users.
    Yu XQ; De Angelis R; Andersson TM; Lambert PC; O'Connell DL; Dickman PW
    Cancer Epidemiol; 2013 Dec; 37(6):836-42. PubMed ID: 24042025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating and modeling the cure fraction in population-based cancer survival analysis.
    Lambert PC; Thompson JR; Weston CL; Dickman PW
    Biostatistics; 2007 Jul; 8(3):576-94. PubMed ID: 17021277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
    Huang L; Cronin KA; Johnson KA; Mariotto AB; Feuer EJ
    Cancer; 2008 May; 112(10):2289-300. PubMed ID: 18393325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proportion cured models applied to 23 cancer sites in Norway.
    Cvancarova M; Aagnes B; Fosså SD; Lambert PC; Møller B; Bray F
    Int J Cancer; 2013 Apr; 132(7):1700-10. PubMed ID: 22927104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The shape of the hazard function in breast carcinoma: curability of the disease revisited.
    Yakovlev AY; Tsodikov AD; Boucher K; Kerber R
    Cancer; 1999 Apr; 85(8):1789-98. PubMed ID: 10223574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival.
    Eloranta S; Lambert PC; Andersson TM; Björkholm M; Dickman PW
    Epidemiology; 2014 Sep; 25(5):742-8. PubMed ID: 25036430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cure for colon cancer: results from the EUROCARE study.
    Verdecchia A; De Angelis R; Capocaccia R; Sant M; Micheli A; Gatta G; Berrino F
    Int J Cancer; 1998 Jul; 77(3):322-9. PubMed ID: 9663589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cure of cancer: a European perspective.
    Francisci S; Capocaccia R; Grande E; Santaquilani M; Simonetti A; Allemani C; Gatta G; Sant M; Zigon G; Bray F; Janssen-Heijnen M;
    Eur J Cancer; 2009 Apr; 45(6):1067-79. PubMed ID: 19131242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
    Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
    Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models.
    Andersson TM; Dickman PW; Eloranta S; Lambert PC
    BMC Med Res Methodol; 2011 Jun; 11():96. PubMed ID: 21696598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.
    Stedman MR; Feuer EJ; Mariotto AB
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):244-54. PubMed ID: 25417238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the loss in expectation of life due to cancer using flexible parametric survival models.
    Andersson TM; Dickman PW; Eloranta S; Lambe M; Lambert PC
    Stat Med; 2013 Dec; 32(30):5286-300. PubMed ID: 24038155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
    Engholm G; Gislum M; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are patients diagnosed with breast cancer before age 50 years ever cured?
    Brenner H; Hakulinen T
    J Clin Oncol; 2004 Feb; 22(3):432-8. PubMed ID: 14691121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Has equity in relative survival improved over time in Finland - a methodological exercise.
    Perme MP; Hakulinen T; Jesenko M; Sankila R; Stare J
    Acta Oncol; 2011 Nov; 50(8):1235-43. PubMed ID: 21812624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the age-at-onset function using life-table methods.
    Chidambaram A; Chakravarti A; Ferrell RE; Iyengar S
    Genet Epidemiol; 1988; 5(4):255-63. PubMed ID: 3169528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ovarian metastasis of extragenital tumors at the Zurich University Gynecologic Clinic 1978-1990].
    Perucchini D; Caduff R; Schär G; Fink D; Köchli OR
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):351-6. PubMed ID: 8964449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Illustration of different modelling assumptions for estimation of loss in expectation of life due to cancer.
    Andersson TM; Rutherford MJ; Lambert PC
    BMC Med Res Methodol; 2019 Jul; 19(1):145. PubMed ID: 31288739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation, precision and validity of 1-year survival estimates for lung, breast, colon and prostate cancer in South East England primary care trusts.
    Lake J; Mak V; Møller H; Davies EA
    Public Health; 2012 Jan; 126(1):57-63. PubMed ID: 22153886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.